A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimers disease: the DARAD trial

1 Effectiveness of antidementia drugs in delaying Alzheimers disease progression Alzheimer's & Dementia, May 2, 2013

2 Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies Journal of Diabetes Investigation, April 29, 2013    Evidence Based Medicine    Review Article

3 Subgroups of Alzheimers Disease Associated with Diabetes Mellitus Based on Brain Imaging Dementia and Geriatric Cognitive Disorders, April 30, 2013    Review Article

4 A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment Dementia and Geriatric Cognitive Disorders, April 30, 2013

5 Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimers disease: a randomized, double-blind study Journal of Neural Transmission, April 25, 2013

6 Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia Alzheimer's & Dementia, May 9, 2013    Evidence Based Medicine    Review Article

7 Effectiveness and Safety of Memantine Treatment for Alzheimers Disease Journal of Alzheimer’s Disease, May 15, 2013

8 A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study Molecular Psychiatry, May 1, 2013
Exclusive Author Commentary

9 Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies The British Journal of Psychiatry, May 3, 2013    Evidence Based Medicine    Review Article

10 Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimers disease Alzheimer's & Dementia, May 13, 2013    Review Article